2011 is shaping up to be a good year for pharma direct-to-consumer (DTC) advertising -- that is, broadcast advertising, NOT Internet advertising.
According to Nielsen data prepared for DTC Perspectives Magazine, total pharma DTC ad spending -- excluding Internet advertising -- increased 3.2% for the first 3 quarters of 2011 vs. the same period in 2010 ($3.045 billion in Q1-Q3 2011 vs. $2.951 in Q1-Q3 2010).
A chart of the top 25 or so drugs promoted in Q1-Q3 2011 in shown below (click on the chart for an enlarged view).
This is good news for TV, which raked in 64% of the broadcast DTC ad dollars during that period and magazines, which raked in 30%. Newspapers and radio shared the scraps left over.
What about Internet DTC spending?
Recall that in October I reported that a representative of Google said "pharma needs to leverage the Internet" and that "pharma was not considered a key client by Google because of pharma's low spend" (see "Double Dip in DTC Ad Spend!").
Of course, Google is concerned primarily with search advertising, which is often said to represent about 40% of the industry's total online advertising spending. But what about online display ads, which are major sources of income for health portal sites such as WebMD?
The Wall Street Journal reported that WebMD's Chief Executive Wayne T. Gattinella resigned, and the health-website operator "called off a search for a buyer as it braces for weaker financial results this year. A key issue, the company said, is pharmaceutical companies holding back on spending as they deal with expiring drug patents." (see "Dip in Drug Ad Spending Leads to WebMD Woes").
- The Coming Pharma Digital Depression Caused by Fac...
- Paula Deen & Victoza: Brilliant or Dumb?
- Allergan "Badly Let Down" by Employee Tweet
- Taking the "Cool" Way Out of Having Rx Product Con...
- Should Pharma Disclose Payments to Celebrity Spoke...
- Participation Grows for the 2012 Membership Market...
- Did FDA Entrap Google with Those 14 NOV Letters?
- Is There a Cure for Mediocre Pharma Mobile Apps?
- Three Companies Compete for Diabetes Market Share ...
- Novo Nordisk Defends Choice of Paula Deen Over Ant...
- Your Membership Value Equation
- A “Good” Response Rate in Membership Marketing
- Pfizer & PhRMA Lobby in Support of SOPA
- My Bad! Paula Dean Shills for Novo Nordisk, Not No...
- Sanofi vs Novartis: Paul Sorvino vs. Paula Deen
- Are You Part of My Social Media Mosaic?
- FDA Sends Warning Letter to Website to Cease & Des...
- Despite Increase in DTC Ad Spending, WebMD Suffers...
- FDA's Advisory Committee Voting Double Standard
- Thera Max YouTube Video "Social Media Strategy" Ma...
- Lilly Sales Reps Learn Marketing Lessons From Disn...
- Predicting the Future of the Drug Industry: 2012 a...
- ▼ January (22)
- ► 2011 (506)
- ► 2010 (268)
- ► 2009 (115)